CERENOME INC
CNSYNASDAQEarnings Aug 12US Equity
$576.32▲ $22.02 (+3.82%)
Simulated price1h—
24h▲ 3.8%
7d—
14d—
30d—
1y—
🏦Market Cap
$209.72B
Large Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
59
Weak
No chart data available for CNSY.
Trading Snapshot
- Day Range
- $569.58 – $586.70
- 52-Week Range
- —
- Volume
- $2.52B
- Avg Volume
- $2.19B
- Shares Outstanding
- —
- Next Earnings
- Oct 18, 2026
Fundamentals Snapshot
- Annual Revenue
- $95.33B
- Last Q Revenue
- $22.39B
- P/E Ratio
- —
- P/S Ratio
- —
- EPS (TTM)
- —
- Dividend Yield
- —
Why Investors Own CNSY
- ✓High-growth profile — revenue up +19.7% YoY with expanding US Equity exposure.
- ✓Healthy economics — 62% gross margin and 13% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$95.33B▲ +20.0% YoY
Gross Margin (TTM)
62.2%▲ +4.1% YoY
Operating Income (TTM)
$15.16B▲ +20.0% YoY
Free Cash Flow (TTM)
$12.77B▲ +20.0% YoY
About CERENOME INC
A company profile for CERENOME INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
59/100
Analyst Price Target
ⓘAverage Target
$748.03
▲ +29.8% Upside
High Target$916.69
Low Target$659.46
Based on 13 analysts
Latest News & Updates
🚀
Barron’s·2h ago
CERENOME INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
MarketWatch·5h ago
Analysts lift CNSY price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
CNBC·1d ago
CERENOME INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.